Janson C, Gislason T, Boman G, Hetta J, Roos B E
Department of Lung Medicine, Uppsala University, Akademiska sjukhuset, Sweden.
Respir Med. 1990 Jan;84(1):37-42. doi: 10.1016/s0954-6111(08)80092-3.
The prevalence of sleep complaints and sleep disturbances was studied prospectively in 98 consecutive adult asthmatic patients (mean age 45 years, 46% men) attending an out-patient clinic by means of questionnaires and sleep diaries. The results were compared with those from an age- and sex-matched group of 226 healthy individuals. The most common sleep disturbances among the asthmatic patients were early morning awakening (51%), difficulty in maintaining sleep (DMS; 44%) and daytime sleepiness (44%). With decreasing asthma control (i.e. increased number of acute asthmatic attacks) there was an increase of DMS, nocturnal wakefulness, nocturnal breathing problems and bronchodilator inhalations at night. A decrease in estimated sleep time (P less than 0.05) and increase in nocturnal wakefulness (P less than 0.05) was seen with decreasing daytime FEV1--measured as percentage of the predicted value (%FEV1). There was also significant correlation between increasing age and decreasing %FEV1 (P less than 0.01). Among the 26 patients who were only taking one oral bronchodilator, no definite difference regarding sleep quality was found between those treated with theophylline and those taking an oral beta 2-agonist. The prevalence rates of DIS, DMS and daytime sleepiness were about twice as high among the asthmatic patients than in the healthy population. It is concluded that impaired quality of sleep, with disturbed sleep during the night, early morning awakenings and daytime sleepiness, is common among patients with bronchial asthma.
通过问卷调查和睡眠日记,对98例连续就诊于门诊的成年哮喘患者(平均年龄45岁,46%为男性)的睡眠主诉和睡眠障碍患病率进行了前瞻性研究。将结果与226名年龄和性别匹配的健康个体进行比较。哮喘患者中最常见的睡眠障碍是早醒(51%)、睡眠维持困难(DMS;44%)和日间嗜睡(44%)。随着哮喘控制程度降低(即急性哮喘发作次数增加),DMS、夜间觉醒、夜间呼吸问题和夜间支气管扩张剂吸入次数增加。随着日间第一秒用力呼气容积(FEV1)降低(以预测值的百分比衡量,%FEV1),估计睡眠时间减少(P<0.05),夜间觉醒增加(P<0.05)。年龄增加与%FEV1降低之间也存在显著相关性(P<0.01)。在仅服用一种口服支气管扩张剂的26例患者中,服用茶碱和口服β2受体激动剂的患者在睡眠质量方面未发现明确差异。哮喘患者中睡眠起始障碍(DIS)、睡眠维持困难(DMS)和日间嗜睡的患病率约为健康人群的两倍。研究得出结论,睡眠质量受损,包括夜间睡眠紊乱、早醒和日间嗜睡,在支气管哮喘患者中很常见。